MyoKardia Long Term Debt 2014-2020 | MYOK

MyoKardia long term debt from 2014 to 2020. Long term debt can be defined as the sum of all long term debt fields.
  • MyoKardia long term debt for the quarter ending June 30, 2020 was $M, a NAN% increase year-over-year.
  • MyoKardia long term debt for 2019 was $0B, a NAN% decline from 2018.
  • MyoKardia long term debt for 2018 was $0B, a NAN% decline from 2017.
  • MyoKardia long term debt for 2017 was $0B, a NAN% decline from 2016.
MyoKardia Annual Long Term Debt
(Millions of US $)
2019 $
2018 $
2017 $
2016 $
2015 $
2014 $
2013 $
MyoKardia Quarterly Long Term Debt
(Millions of US $)
2020-06-30
2020-03-31
2019-12-31
2019-09-30
2019-06-30
2019-03-31
2018-12-31
2018-09-30
2018-06-30
2018-03-31
2017-12-31
2017-09-30
2017-06-30
2017-03-31
2016-12-31
2016-09-30
2016-06-30
2016-03-31
2015-12-31
2015-09-30
2015-06-30
2015-03-31
2014-12-31
2014-09-30
2014-06-30
2013-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $6.903B $0.034B
MyoKardia, Inc. is a biopharmaceutical company. The company focuses on discovering, developing, and commercializing therapies for the treatment of serious and neglected rare cardiovascular diseases. Its product candidate consists of MYK-461, a small molecule to reduce excessive cardiac muscle contractility leading to hypertrophic cardiomyopathy, DCM-1, treats heritable dilated cardiomyopathy by restoring normal contractility in the diseased DCM heart, HCM-2, a product candidate to reduce cardiac muscle contractility to normal levels in HCM patients and LUS-1, which is intended to counteract a muscle disruption that results in impaired relaxation of the heart, which are in different clinical trial. MyoKardia, Inc. is headquartered in San Francisco, California.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $145.299B 15.78
Bristol Myers Squibb (BMY) United States $134.404B 10.35
CSL (CSLLY) Australia $95.311B 0.00
Gilead Sciences (GILD) United States $81.542B 11.74
Vertex Pharmaceuticals (VRTX) United States $70.706B 39.46
Regeneron Pharmaceuticals (REGN) United States $60.112B 22.99
Biogen (BIIB) United States $43.595B 7.46
Illumina (ILMN) United States $43.511B 50.60
Seattle Genetics (SGEN) United States $30.564B 0.00
Moderna (MRNA) United States $26.789B 0.00
Alexion Pharmaceuticals (ALXN) United States $25.014B 10.42
Genmab (GMAB) Denmark $24.574B 15.52
BeiGene (BGNE) Cayman Islands $23.647B 0.00
Genmab (GNMSF) Denmark $22.914B 5.28
SINO PHARMACEUT (SBMFF) Hong Kong, SAR China $21.148B 0.00
Incyte (INCY) United States $19.775B 0.00
Immunomedics (IMMU) United States $19.726B 0.00
Horizon Therapeutics Public (HZNP) Ireland $16.096B 37.66
Alnylam Pharmaceuticals (ALNY) United States $15.194B 0.00
BioNTech SE (BNTX) Germany $15.110B 0.00
Bio-Rad Laboratories (BIO.B) United States $14.252B 64.46
BioMarin Pharmaceutical (BMRN) United States $14.211B 103.11
ARGENX SE-ADR (ARGX) Netherlands $11.492B 0.00
QIAGEN (QGEN) Netherlands $11.369B 28.85
Sarepta Therapeutics (SRPT) United States $11.307B 0.00
Exact Sciences (EXAS) United States $11.246B 0.00
Guardant Health (GH) United States $10.017B 0.00
Bio-Techne Corp (TECH) United States $9.455B 64.88
Galapagos (GLPG) Belgium $9.207B 33.36
Exelixis (EXEL) United States $8.324B 30.27
Ascendis Pharma (ASND) Denmark $7.700B 0.00
Repligen (RGEN) United States $7.650B 121.43
SWEDISH ORP BIO (BIOVF) Sweden $7.574B 18.84
Mirati Therapeutics (MRTX) United States $7.214B 0.00
Novavax (NVAX) United States $7.078B 0.00
ACADIA Pharmaceuticals (ACAD) United States $6.427B 0.00
Acceleron Pharma (XLRN) United States $6.243B 0.00
Momenta Pharmaceuticals (MNTA) United States $6.229B 0.00
Adaptive Biotechnologies (ADPT) United States $6.093B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $5.974B 185.09
Emergent Biosolutions (EBS) United States $5.379B 21.31
Ultragenyx Pharmaceutical (RARE) United States $4.994B 0.00
Zai Lab (ZLAB) China $4.697B 0.00
MorphoSys AG (MOR) Germany $4.439B 58.17
China Biologic Products (CBPO) China $4.399B 26.11
Legend Biotech (LEGN) United States $4.359B 0.00
Blueprint Medicines (BPMC) United States $4.330B 0.00
Denali Therapeutics (DNLI) United States $4.116B 0.00
Arena Pharmaceuticals (ARNA) United States $4.069B 0.00
Vir Biotechnology (VIR) United States $4.067B 0.00
NeoGenomics (NEO) United States $3.850B 1162.00
Halozyme Therapeutics (HALO) United States $3.841B 0.00
Bluebird Bio (BLUE) United States $3.703B 0.00
Amicus Therapeutics (FOLD) United States $3.602B 0.00
Reata Pharmaceuticals (RETA) United States $3.473B 0.00
Insmed (INSM) United States $3.367B 0.00
Global Blood Therapeutics (GBT) United States $3.355B 0.00
Principia Biopharma (PRNB) United States $3.323B 0.00
Fate Therapeutics (FATE) United States $3.205B 0.00
Deciphera Pharmaceuticals (DCPH) United States $2.964B 0.00
Alkermes (ALKS) Ireland $2.934B 61.50
Twist Bioscience (TWST) United States $2.893B 0.00
Inovio Pharmaceuticals (INO) United States $2.625B 0.00
Sorrento Therapeutics (SRNE) United States $2.294B 0.00
PHARMA MAR SA (PHMMF) Spain $2.214B 0.00
I-Mab (IMAB) China $2.156B 0.00
Revance Therapeutics (RVNC) United States $2.117B 0.00
Mesoblast (MESO) Australia $2.111B 0.00
Intra-Cellular Therapies (ITCI) United States $2.084B 0.00
Seres Therapeutics (MCRB) United States $2.048B 0.00
Editas Medicine (EDIT) United States $2.036B 0.00
BAVARIAN NORDIC (BVNRY) Denmark $2.006B 22.47
Zymeworks (ZYME) Canada $1.978B 0.00
Eidos Therapeutics (EIDX) United States $1.923B 0.00
UniQure (QURE) Netherlands $1.853B 0.00
Akcea Therapeutics (AKCA) United States $1.843B 0.00
Forma Therapeutics Holdings (FMTX) United States $1.804B 0.00
Viela Bio (VIE) United States $1.754B 0.00
Mersana Therapeutics (MRSN) United States $1.658B 0.00
Amarin (AMRN) Ireland $1.619B 0.00
Cytokineticsorporated (CYTK) United States $1.534B 0.00
Sangamo Therapeutics (SGMO) United States $1.520B 0.00
Ligand Pharmaceuticals (LGND) United States $1.514B 51.17
Zealand Pharma (ZEAL) Denmark $1.472B 0.00
Beam Therapeutics (BEAM) United States $1.469B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.459B 0.00
Arcus Biosciences (RCUS) United States $1.440B 0.00
Intercept Pharmaceuticals (ICPT) United States $1.439B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $1.399B 0.00
Coherus BioSciences (CHRS) United States $1.363B 7.95
Zealand Pharma (ZLDPF) Denmark $1.339B 0.00
Epizyme (EPZM) United States $1.331B 0.00
Intellia Therapeutics (NTLA) United States $1.319B 0.00
NGM Biopharmaceuticals (NGM) United States $1.315B 0.00
Compugen (CGEN) Israel $1.243B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.143B 0.00
Alector (ALEC) United States $1.118B 0.00
Alcobra (ARCT) United States $1.110B 0.00
REGENXBIO (RGNX) United States $1.102B 0.00
Athenex (ATNX) United States $1.067B 0.00
Arvinas (ARVN) United States $1.052B 0.00
Adverum Biotechnologies (ADVM) United States $1.035B 0.00
Retrophin (RTRX) United States $1.001B 0.00
Pliant Therapeutics (PLRX) United States $0.979B 0.00
Castle Biosciences (CSTL) United States $0.956B 0.00
Agenus (AGEN) United States $0.952B 0.00
Myriad Genetics (MYGN) United States $0.937B 0.00
Heska (HSKA) United States $0.913B 0.00
NantKwest (NK) United States $0.899B 0.00
Morphic Holding (MORF) United States $0.885B 0.00
VBI Vaccines (VBIV) United States $0.869B 0.00
OXFORD BIOMEDCL (OXBDF) United Kingdom $0.864B 0.00
Cellectis S.A (CLLS) France $0.864B 0.00
Vericel (VCEL) United States $0.859B 0.00
Intrexon (PGEN) United States $0.843B 0.00
Frequency Therapeutics (FREQ) United States $0.835B 0.00
Protagonist Therapeutics (PTGX) United States $0.780B 0.00
Kadmon Holdings (KDMN) United States $0.770B 0.00
Pharming Group (PHGUF) Netherlands $0.745B 17.00
MiMedx (MDXG) United States $0.711B 0.00
Codexis (CDXS) United States $0.710B 0.00
WAVE Life Sciences (WVE) Singapore $0.696B 0.00
Cara Therapeutics (CARA) United States $0.693B 0.00
Northwest Biotherapeutics (NWBO) United States $0.691B 0.00
Clovis Oncology (CLVS) United States $0.660B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.658B 0.00
AC Immune SA (ACIU) Switzerland $0.642B 0.00
Sinovac Biotech (SVA) China $0.640B 43.13
Autolus Therapeutics (AUTL) United Kingdom $0.630B 0.00
Dynavax Technologies (DVAX) United States $0.618B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.604B 0.00
Basilea Pharmaceutica AG (BPMUF) Switzerland $0.596B 0.00
Albireo Pharma (ALBO) United States $0.585B 0.00
Aquinox Pharmaceuticals (NLTX) United States $0.585B 0.00
Geron (GERN) United States $0.571B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.543B 4.75
Scholar Rock Holding (SRRK) United States $0.534B 0.00
Forte Biosciences (FBRX) United States $0.532B 0.00
IVERIC Bio (ISEE) United States $0.527B 0.00
Anika Therapeutics (ANIK) United States $0.521B 22.79
Cue Biopharma (CUE) United States $0.508B 0.00
Orchard Therapeutics (ORTX) United Kingdom $0.503B 0.00
Cel-Sci (CVM) United States $0.492B 0.00
Kala Pharmaceuticals (KALA) United States $0.490B 0.00
MeiraGTx Holdings (MGTX) United States $0.489B 0.00
Celldex Therapeutics (CLDX) United States $0.474B 0.00
UROGEN PHARMA (URGN) United States $0.467B 0.00
Starpharma Holdings (SPHRY) Australia $0.451B 0.00
MannKind (MNKD) United States $0.442B 0.00
Avid Bioservices (CDMO) United States $0.439B 0.00
Amryt Pharma (AMYT) United Kingdom $0.437B 0.00
Syros Pharmaceuticals (SYRS) United States $0.436B 0.00
Pfenex (PFNX) United States $0.436B 0.00
AnaptysBio (ANAB) United States $0.432B 0.00
Prothena (PRTA) Ireland $0.415B 0.00
IBio (IBIO) United States $0.410B 0.00
BioDelivery Sciences (BDSI) United States $0.409B 28.93
Athersys (ATHX) United States $0.407B 0.00
Puma Biotechnology (PBYI) United States $0.400B 0.00
Kamada (KMDA) Israel $0.400B 19.11
Sutro Biopharma (STRO) United States $0.398B 0.00
Fortress Biotech (FBIO) United States $0.395B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.386B 0.00
PDL BioPharma (PDLI) United States $0.369B 0.00
ANI Pharmaceuticals (ANIP) United States $0.367B 8.67
Bicycle Therapeutics (BCYC) United Kingdom $0.365B 0.00
Cellular Biomedicine (CBMG) United States $0.361B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.347B 0.00
Merus (MRUS) Netherlands $0.338B 0.00
CytomX Therapeutics (CTMX) United States $0.332B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.326B 0.00
Innate Pharma S.A (IPHA) France $0.321B 0.00
Precision BioSciences (DTIL) United States $0.311B 0.00
Menlo Therapeutics (VYNE) United States $0.304B 0.00
Prometic Life Sciences (LMNL) Canada $0.297B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.296B 0.00
Trevena (TRVN) United States $0.292B 0.00
Selecta Biosciences (SELB) United States $0.283B 0.00
Affimed (AFMD) Germany $0.282B 0.00
ChromaDex (CDXC) United States $0.280B 0.00
Cyclerion Therapeutics (CYCN) United States $0.276B 0.00
OSMOTICA PHARM (OSMT) United States $0.265B 0.00
NextCure (NXTC) United States $0.259B 0.00
Pluristem Therapeutics (PSTI) Israel $0.249B 0.00
Arbutus Biopharma (ABUS) United States $0.247B 0.00
HOOKIPA Pharma (HOOK) United States $0.243B 0.00
Verastem (VSTM) United States $0.231B 0.00
TELA Bio (TELA) United States $0.225B 0.00
Liquidia Technologies (LQDA) United States $0.223B 0.00
XOMA (XOMA) United States $0.222B 0.00
DBV Technologies S.A (DBVT) France $0.218B 0.00
Dyadic (DYAI) United States $0.213B 0.00
Cerecor (CERC) United States $0.213B 0.00
Spero Therapeutics (SPRO) United States $0.212B 0.00
Checkpoint Therapeutics (CKPT) United States $0.211B 0.00
ADMA Biologics Inc (ADMA) United States $0.208B 0.00
Aduro Biotech (ADRO) United States $0.202B 0.00
Biofrontera AG (BFRA) Germany $0.199B 0.00
Kindred Biosciences (KIN) United States $0.193B 0.00
Theratechnologies (THTX) Canada $0.191B 0.00
Cardiff Oncology (CRDF) United States $0.188B 0.00
POXEL SA FRANCE (PXXLF) France $0.188B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.182B 8.50
GENFIT S.A (GNFT) France $0.180B 0.00
Exicure (XCUR) United States $0.177B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.172B 0.00
Eton Pharmaceuticals (ETON) United States $0.170B 0.00
Aytu Bioscience (AYTU) United States $0.166B 0.00
Abeona Therapeutics (ABEO) United States $0.166B 0.00
Lineage Cell Therapeutics (LCTX) United States $0.163B 0.00
Aptinyx (APTX) United States $0.161B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.157B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.157B 0.00
VolitionRX (VNRX) United States $0.154B 0.00
CorMedix Inc (CRMD) United States $0.147B 0.00
Nicox SA (NICXF) France $0.146B 0.00
Five Prime Therapeutics (FPRX) United States $0.145B 0.00
AquaBounty Technologies (AQB) United States $0.145B 0.00
Bellus Health (BLU) Canada $0.144B 0.00
VTv Therapeutics (VTVT) United States $0.144B 0.00
Celyad SA (CYAD) Belgium $0.141B 0.00
Cidara Therapeutics (CDTX) United States $0.140B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.132B 0.00
SESEN BIO, INC (SESN) United States $0.132B 0.00
Applied Genetic Technologies (AGTC) United States $0.131B 0.00
Gritstone Oncology (GRTS) United States $0.126B 0.00
Strongbridge Biopharma (SBBP) United States $0.121B 0.00
Windtree Therapeutics (WINT) United States $0.120B 0.00
Lumos Pharma (LUMO) United States $0.120B 0.00
Vaccinex (VCNX) United States $0.119B 0.00
Palatin Technologies (PTN) United States $0.119B 3.04
Protalix BioTherapeutics (PLX) Israel $0.114B 0.00
Enzo Biochem (ENZ) United States $0.114B 0.00
Unum Therapeutics (UMRX) United States $0.109B 0.00
Antibe Therapeutics (ATBPF) Canada $0.107B 0.00
Catalyst Biosciences (CBIO) United States $0.107B 0.00
Orgenesis (ORGS) United States $0.106B 5.38
PHASEBIO PHARMA (PHAS) United States $0.103B 0.00
AIT Therapeutics (XAIR) United States $0.094B 0.00
ARAVIVE, INC (ARAV) United States $0.093B 0.00
Idera Pharmaceuticals (IDRA) United States $0.092B 0.00
Bionano Genomics (BNGO) United States $0.087B 0.00
Oncobiologics (OTLK) United States $0.084B 0.00
DiaMedica Therapeutics (DMAC) United States $0.083B 0.00
Adocia (ADOCY) France $0.080B 0.00
Clearside Biomedical (CLSD) United States $0.078B 0.00
Ecology Coatings (ABVC) United States $0.078B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.076B 0.00
Synlogic (SYBX) United States $0.074B 0.00
Edesa Biotech (EDSA) Canada $0.069B 0.00
AmpliPhi Biosciences (ARMP) United States $0.068B 0.00
Evogene (EVGN) Israel $0.067B 0.00
Proteostasis Therapeutics (PTI) United States $0.066B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.065B 0.00
Emmaus Life Sciences (EMMA) United States $0.064B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.063B 0.00
TRACON Pharmaceuticals (TCON) United States $0.063B 0.00
Prima BioMed (IMMP) Australia $0.062B 0.00
Curis (CRIS) United States $0.061B 0.00
AnPac Bio-Medical Science (ANPC) China $0.058B 0.00
Soligenix (SNGX) United States $0.058B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.056B 0.00
Vascular Biogenics (VBLT) Israel $0.056B 0.00
Cocrystal Pharma (COCP) United States $0.054B 0.00
Stealth BioTherapeutics (MITO) United States $0.053B 76.00
Genetic Technologies (GENE) Australia $0.052B 0.00
Happiness Biotech Group (HAPP) China $0.050B 0.00
Signal Genetics (MGEN) United States $0.050B 0.00
Novogen (KZIA) Australia $0.050B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.049B 0.00
Organovo Holdings (ONVO) United States $0.046B 0.00
IMMURON (IMRN) Australia $0.046B 0.00
CollPlant Holdings (CLGN) Israel $0.046B 0.00
Pulmatrix (PULM) United States $0.043B 0.00
ATyr Pharma (LIFE) United States $0.040B 0.00
Prana Biotechnology (ATHE) Australia $0.035B 0.00
Chanticleer Holdings (SONN) United States $0.034B 0.00
OvaScience (MLND) United States $0.031B 0.00
Apricus Biosciences (SEEL) United States $0.029B 0.00
BioCardia (BCDA) United States $0.029B 0.00
Advaxis (ADXS) United States $0.029B 0.00
Alimera Sciences (ALIM) United States $0.028B 0.00
Acorda Therapeutics (ACOR) United States $0.028B 0.00
Cleveland BioLabs (CBLI) United States $0.027B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.027B 0.00
Celsion (CLSN) United States $0.027B 0.00
Aptevo Therapeutics (APVO) United States $0.025B 0.00
Cesca Therapeutics (THMO) United States $0.024B 0.00
PLANET GREEN HOLDINGS CORP (PLAG) China $0.020B 0.00
Spherix (AIKI) United States $0.020B 0.00
AEterna Zentaris (AEZS) United States $0.020B 0.00
Titan Pharmaceuticals (TTNP) United States $0.020B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.018B 0.00
MYOS RENS Technology (MYOS) United States $0.017B 0.00
BioPharmX (TMBR) United States $0.012B 0.00
Neuralstem (SNCA) United States $0.011B 0.00
Benitec Biopharma (BNTC) Australia $0.008B 0.00
Entera Bio (ENTX) Israel $0.000B 0.00